NO980058L - Opthalmiske preparater - Google Patents

Opthalmiske preparater

Info

Publication number
NO980058L
NO980058L NO980058A NO980058A NO980058L NO 980058 L NO980058 L NO 980058L NO 980058 A NO980058 A NO 980058A NO 980058 A NO980058 A NO 980058A NO 980058 L NO980058 L NO 980058L
Authority
NO
Norway
Prior art keywords
ophthalmic preparations
ophthalmic
prostaglandin
phenylene
inter
Prior art date
Application number
NO980058A
Other languages
English (en)
Other versions
NO980058D0 (no
Inventor
Takashi Ikari
Yuzuru Matsumura
Tsutomu Nakamura
Motoyuki Yajima
Hajimu Kurumatani
Ayako Kawashima
Musafumi Isogaya
Hisanori Wakita
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of NO980058D0 publication Critical patent/NO980058D0/no
Publication of NO980058L publication Critical patent/NO980058L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Oftalmiske preparater som utviser glimrende farmakologisk effekt overfor forskjellige Oftalmiske sykdom- mer, som omfatter 4,8-inter-m-fenylen- prostaglandin I2-derivater av generell formel I (I) eller farmakologisk akseptable salter derav som aktive bestanddeler.
NO980058A 1996-05-07 1998-01-06 Opthalmiske preparater NO980058L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13769796 1996-05-07
PCT/JP1997/001504 WO1997041864A1 (fr) 1996-05-07 1997-05-01 Preparations ophtalmiques

Publications (2)

Publication Number Publication Date
NO980058D0 NO980058D0 (no) 1998-01-06
NO980058L true NO980058L (no) 1998-03-06

Family

ID=15204703

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980058A NO980058L (no) 1996-05-07 1998-01-06 Opthalmiske preparater

Country Status (9)

Country Link
US (1) US6232343B1 (no)
EP (1) EP0842663A4 (no)
KR (1) KR19990028646A (no)
CN (1) CN1126545C (no)
AU (1) AU734650B2 (no)
CA (1) CA2226348A1 (no)
NO (1) NO980058L (no)
TW (1) TW487573B (no)
WO (1) WO1997041864A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19980701417A (ko) * 1995-11-14 1998-05-15 마에다 카쯔노수케 안압저하제(agent for decreasing ocular tension)
NZ505163A (en) 1997-12-26 2002-11-26 Yamanouchi Pharma Co Ltd Sustained release medicinal compositions comprising an ionic compound with an opposite charge to the ionic active substance
US6804136B2 (en) 2002-06-21 2004-10-12 Micron Technology, Inc. Write once read only memory employing charge trapping in insulators
US6933289B2 (en) * 2003-07-01 2005-08-23 Allergan, Inc. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
WO2007076448A2 (en) * 2005-12-23 2007-07-05 Alcon, Inc. Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye
US8912236B2 (en) * 2009-03-03 2014-12-16 Alcon Research, Ltd. Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye
MX2011008731A (es) * 2009-03-03 2011-09-29 Alcon Res Ltd Composicion farmaceutica para el suministro de compuestos inhibidores de la tirosina cinasa receptora (rtki) para los ojos.
AU2010221438C1 (en) * 2009-03-03 2015-01-29 Alcon Research, Ltd. Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye
CN102319213B (zh) * 2011-09-08 2013-05-08 北京泰德制药股份有限公司 一种贝前列素酸纳米脂微球制剂
US9744192B2 (en) * 2015-03-16 2017-08-29 Lee A. Flippin Methods of treating chronic rhinosinusitis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE8200407U1 (de) * 1982-01-11 1982-07-01 Fr. Poggenpohl KG, Möbelwerke, 4900 Herford Anbau-kuechenschrank
JPS58124778A (ja) 1982-01-20 1983-07-25 Toray Ind Inc ５，６，７−トリノル−４，８−インタ−ｍ−フエニレンＰＧＩ↓２誘導体
JPH0348655A (ja) * 1989-07-14 1991-03-01 Shionogi & Co Ltd プロスタグランジンｄ↓２類の安定化
TW205508B (no) 1990-08-02 1993-05-11 Kabushikaisha Ueno Seiyaku Oyo Kenkyujo
JP3573480B2 (ja) * 1994-02-21 2004-10-06 大正製薬株式会社 プロスタグランジン誘導体およびその使用
KR19980701417A (ko) * 1995-11-14 1998-05-15 마에다 카쯔노수케 안압저하제(agent for decreasing ocular tension)

Also Published As

Publication number Publication date
AU734650B2 (en) 2001-06-21
CN1196681A (zh) 1998-10-21
WO1997041864A1 (fr) 1997-11-13
AU2650697A (en) 1997-11-26
CN1126545C (zh) 2003-11-05
KR19990028646A (ko) 1999-04-15
EP0842663A1 (en) 1998-05-20
EP0842663A4 (en) 2003-06-18
NO980058D0 (no) 1998-01-06
TW487573B (en) 2002-05-21
CA2226348A1 (en) 1997-11-13
US6232343B1 (en) 2001-05-15

Similar Documents

Publication Publication Date Title
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
DE69528005T2 (de) Prolineamid-Derivate
SE9504661D0 (sv) New compounds
NO20012977D0 (no) N-ureidoalkylpiperidiner som modulatorer av chemokinreseptoraktivitet
CA2183972A1 (en) Oxazolidinone derivatives and pharmaceutical compositions containing them
MXPA03011510A (es) Derivados de5-halo-triptamina usados como ligandos de receptores de serotonina 5-ht-6 y/o 5-ht-7.
HUP0003571A2 (hu) 6,9-Hídkötésű eritromicin-származékok
IT1255802B (it) Derivati imidazolici ad attivita' a ii antagonista
NO980058L (no) Opthalmiske preparater
ATE242220T1 (de) Benzimidazolderivate mit dopaminerger wirkung
IT1276162B1 (it) Geranilgeranil-derivati,procedimento per la loro preparazione e relative composizioni farmaceutiche
DE60128100D1 (de) Analgetisches arzneimittel
DE69819539D1 (de) Antithrombotische mittel
DK1204658T3 (da) Benzofurylpiperazin-serotoninagonister
TR199701202T1 (xx) Yeni hidroksimik asit t�revleri.
NO983444L (no) Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
SE9504662D0 (sv) New compounds
UA41350C2 (uk) Похідна морфоліну або її фармацевтично прийнятна сіль та фармацевтична композиція на її основі
DE69828390D1 (de) Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung
AU7470098A (en) Antithrombotic agents
ATE293635T1 (de) Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen
AU4944899A (en) New pharmaceutically active compounds
TR199900013T2 (xx) Yeni bile�ikler.
DK1232173T3 (da) Nye fusidinsyrederivater
NO20001846L (no) Nye farmasøytisk aktive forbindelser, deres fremstilling og anvendelse som ECE-inhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application